ACTIVE_NOT_RECRUITING

Using Technology to Address Disparities and Promote Healthcare Equity in Type 1 Diabetes Registry

Conditions

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This study is being done to see if using technology, with the help of a Patient Navigator, can help address disparities, improve outcomes, and promote healthcare equity in type 1 diabetes.

Official Title

Using Technology to Address Disparities and Promote Healthcare Equity in Type 1 Diabetes Registry

Quick Facts

Study Start:2020-11-20

Study Completion:2027-03

Study Type:Not specified

Phase:Not Applicable

Enrollment:Not specified

Status:ACTIVE_NOT_RECRUITING

Study ID

NCT06899984

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:14 Years to 64 Years

Sexes Eligible for Study:ALL

Accepts Healthy Volunteers:No

Standard Ages:CHILD, ADULT

Inclusion Criteria	Exclusion Criteria
* Males or females age 14 to 64 years * Clinical diagnosis of type 1 diabetes (T1D) * Two or more hospitalizations with diabetic ketoacidosis (DKA) within the past 5 years or hemoglobin A1c greater than 10% on two or more laboratory samples in the last 2 years. * Informed Consent * Has a CGMS or a prescription for a CGMS as part of their clinical care as part of their clinical care	* Inability or unwillingness to share CGMS data with the study team

Contacts and Locations

Principal Investigator

Celeste Thomas, MD

PRINCIPAL_INVESTIGATOR

University of Chicago

Study Locations (Sites)

University of Chicago

Chicago, Illinois, 60637

United States

Collaborators and Investigators

Sponsor: University of Chicago

Celeste Thomas, MD, PRINCIPAL_INVESTIGATOR, University of Chicago

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2020-11-20

Study Completion Date2027-03

Study Record Updates

Study Start Date2020-11-20

Study Completion Date2027-03

Terms related to this study

Additional Relevant MeSH Terms

Diabetes Mellitus, Type 1